Dermavant Sciences Inc.
Dermavant Sciences, a subsidiary of Roivant Sciences, is a biopharmaceutical company committed to fostering unprecedented change and unparalleled impact in immuno-dermatology. Our mission is to make healthier skin a reality for the millions of people around the world living with chronic skin conditions. That’s why we’re hard at work developing novel treatments that deliver groundbreaking science exactly where patients need it — their skin. Because skin is more than superficial — it’s where we live, every moment of every day.
3780 Kilroy Airport
Suite 250
Long Beach, CA 90806 US
Suite 250
Long Beach, CA 90806 US
NEWS
As August wraps up, there were still clinical trial announcements, although fewer than earlier this summer. Here’s a look.
The trials were identical, multi-center, randomized, vehicle-controlled, double-blind, parallel studies that evaluated tapinarof cream, 1% in adults with plaque psoriasis.
It was a fairly busy week with clinical trial updates and announcements. Here’s a look.
Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.
In the lead-up to the ASCO Annual Meeting, companies were presenting some of their trial data, while other companies were presenting news related to COVID-19 studies. Here’s a look.
Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.
Pharma and life sciences companies strengthen their leadership and boards with this week’s appointments.
Companies from across the globe provide updates to their business and pipeline.
Biotech and pharma companies bring on new talent to strengthen leadership teams and boards.
JOBS
IN THE PRESS